Johnson & Johnson
Latest statistics and disclosures from Johnson & Johnson's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PTGX, NBTX, RAPP, MGTX, CVRX, and represent 86.45% of Johnson & Johnson's stock portfolio.
- Added to shares of these 1 stock: ACET.
- Started 1 new stock position in ACET.
- Reduced shares in these 5 stocks: ARWR (-$8.5M), CVRX, Adicet Bio, Chardan Healthcare Acqu- Ord, Senseonics Hldgs.
- Sold out of its positions in Adicet Bio, ARWR, Chardan Healthcare Acqu- Ord, Senseonics Hldgs.
- Johnson & Johnson was a net seller of stock by $-9.3M.
- Johnson & Johnson has $555M in assets under management (AUM), dropping by 10.11%.
- Central Index Key (CIK): 0000200406
Tip: Access up to 7 years of quarterly data
Positions held by Johnson & Johnson consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Johnson & Johnson
Johnson & Johnson holds 17 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Protagonist Therapeutics (PTGX) | 38.6 | $214M | 2.4M | 87.34 |
|
|
| Nanobiotix Sponsored Ads (NBTX) | 23.4 | $130M | 5.6M | 23.12 |
|
|
| Rapport Therapeutics (RAPP) | 9.8 | $54M | 1.8M | 30.34 |
|
|
| Meiragtx Holdings (MGTX) | 9.5 | $53M | 6.6M | 7.95 |
|
|
| CVRX (CVRX) | 5.2 | $29M | 4.0M | 7.10 |
|
|
| Contineum Therapeutics Cl A (CTNM) | 4.1 | $23M | 2.0M | 11.43 |
|
|
| Legend Biotech Corporation Sponsored Ads (LEGN) | 3.2 | $18M | 815k | 21.74 |
|
|
| Xencor (XNCR) | 2.1 | $12M | 748k | 15.31 |
|
|
| Procept Biorobotics Corp (PRCT) | 2.0 | $11M | 358k | 31.46 |
|
|
| Fate Therapeutics (FATE) | 0.6 | $3.3M | 3.4M | 0.98 |
|
|
| Neumora Therapeutics (NMRA) | 0.6 | $3.3M | 1.8M | 1.79 |
|
|
| Rallybio Corp (RLYB) | 0.4 | $2.5M | 3.6M | 0.69 |
|
|
| Lyell Immunopharma Com New (LYEL) | 0.2 | $1.3M | 41k | 30.78 |
|
|
| Vor Biopharma Com New (VOR) | 0.1 | $703k | 54k | 13.08 |
|
|
| Nano-X Imaging Ord Shs (NNOX) | 0.1 | $445k | 159k | 2.80 |
|
|
| D Fluidigm Corp Del (LAB) | 0.1 | $399k | 312k | 1.28 |
|
|
| Adicet Bio Com New (ACET) | 0.0 | $192k | NEW | 23k | 8.42 |
|
Past Filings by Johnson & Johnson
SEC 13F filings are viewable for Johnson & Johnson going back to 2021
- Johnson & Johnson 2025 Q4 filed Feb. 13, 2026
- Johnson & Johnson 2025 Q3 filed Nov. 13, 2025
- Johnson & Johnson 2025 Q2 filed July 22, 2025
- Johnson & Johnson 2025 Q1 filed May 7, 2025
- Johnson & Johnson 2024 Q4 filed Feb. 13, 2025
- Johnson & Johnson 2024 Q3 filed Nov. 13, 2024
- Johnson & Johnson 2024 Q2 filed Aug. 9, 2024
- Johnson & Johnson 2024 Q1 filed May 10, 2024
- Johnson & Johnson 2023 Q3 filed Nov. 9, 2023
- Johnson & Johnson 2023 Q2 filed Aug. 2, 2023
- Johnson & Johnson 2023 Q1 filed May 11, 2023
- Johnson & Johnson 2022 Q4 filed Feb. 9, 2023
- Johnson & Johnson 2022 Q3 filed Nov. 10, 2022
- Johnson & Johnson 2022 Q2 filed Aug. 10, 2022
- Johnson & Johnson 2022 Q1 filed May 9, 2022
- Johnson & Johnson 2021 Q4 filed Feb. 14, 2022